ADAM10 inhibits RhoA and Notch activation induced by exonucleosome treatment, and down-regulation of ADAM10 expression in TIMP-free fibroblasts reduces their tumor-promoting and metastatic potential in vivo (128). This evidence concerns the gene ADAM10 and neoplasm.